| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | -0.0075 | 0.8 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | -0.0078 | 0.8 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | -0.0089 | 0.8 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | 0.0078 | 0.8 |
| mRNA | pac-1 | GDSC1000 | pan-cancer | AAC | -0.0075 | 0.8 |
| mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | -0.0074 | 0.8 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.0063 | 0.8 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | 0.0083 | 0.8 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0073 | 0.8 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | -0.0069 | 0.8 |